etrasimod api

Etrasimod (1206123-37-6) Etrasimod is a novel oral, selective sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of adult patients with moderately to severely active ulcerative colitis. It functions by partially and reversibly blocking lymphocyte outflow, reducing peripheral blood lymphocyte counts, thereby limiting lymphocyte migration to the intestines and delivering therapeutic benefits. Product Specifications Product Name: Etrasimod CAS No.: